Skip to main content

Will 2024 Be An Active Year For German Cannabis Reform?

With 2024 now in full swing, the eyes of the international cannabis community remain fixed on Germany where lawmakers continue to work to pass the nation’s adult-use CanG cannabis law, an effort that has seemingly languished since it started back in 2021.

Last year was full of ups and downs in Germany, with a Bundestag vote expected, just to then be unceremoniously dashed, multiple times during 2023. According to Deutscher Hanfverband (DHV), a Bundestag vote is still expected later this month:

DHV reached out to factions from Germany’s coalition government earlier this month, and while members of the Greens and FDP responded, members of the SPD parliamentary group did not. The SPD parliamentary group has received considerable blame for ongoing legalization delays.

“Due to the postponement of the CanG from the Bundestag agenda and the ongoing debates in the SPD parliamentary group, we asked all traffic light factions about the status of things. The Greens and FDP responded, the SPD parliamentary group did not.” DHV stated.

“In a joint press release on November 27th, 2023, the traffic light factions announced that they had “agreed in the negotiations on a paradigm shift in cannabis policy”. (https://www.gruene-bundestag.de/presse/pressemitigungen/ampel-ein-sich-auf-cannabis-gesetz). The subsequent reporting was accurate and the agreement stands. The substantive negotiations have been completed. Since then, no other negotiations, including at a higher level, have taken place between the traffic light factions. The changes must now be decided by the Health Committee and the law must be passed in an amended version by the Bundestag. This can take place within one week of the meeting. We Greens are striving for a timely adoption.” Green Party’s spokesperson Kirsten Kappert-Gonther told DHV.

“It is a common goal of our coalition to pass the cannabis law in the German Bundestag as quickly as possible. Thoroughness is more important than speed. A practical and sensible law is more important to us than a hasty law. In the negotiations between the political groups, we are always careful to take all interests into account. On the one hand, the protection of minors and health, security and criminal prosecution must be ensured; on the other hand, social realities and the right to self-determination must not be neglected. Despite internal coordination problems within the SPD parliamentary group, we are extremely confident that we will be able to complete the legislative process with our coalition partners in the near future. Our aim is to enable responsible and legal use of cannabis.” Christine Aschenberg-Dugnus, Parliamentary Managing Director of the Free Democrats Group told DHV.

Bundestag member Dr. Rolf Mützenich (SPD) was previously asked by a constituent in recent weeks, “Dear Mr. Mützenich, are you worried about the citizens’ severe loss of trust in the SPD due to the repeated postponement of the vote on the CanG or does it not matter to you?”

Dr. Mützenich replied publicly with, “The SPD parliamentary group continues to support the bill to decriminalize cannabis. It is regrettable that other reports spread a false impression – perhaps deliberately. The SPD has long campaigned for a liberal drug policy and failed to do so due to the Union under Chancellor Merkel.”

“We are now committed to ensuring that the law will, above all, take health protection into account; final discussions are still being held on this matter. The law is scheduled to be passed at the beginning of next year and, we intend, to come into force in April 2024 as planned.” Dr. Mützenich also stated.

Further changes to CanG appear to be on the way, although it remains unclear what those changes are. Still, the timeline for approval appears to be on pace:

Meanwhile, adult-use cannabis or not, members of Germany’s established medical cannabis industry are calling for wider regulatory reform in the nation’s medical sector. All of it is adding to what will likely be a very busy year for cannabis policy modernization efforts in Germany in 2024.

Cannabis Clubs Are Here To Stay In Barcelona, Spain

Barcelona Mayor Jaume Collboni and the Barcelona City Council are ramping up efforts to close down the city’s famed cannabis clubs, with the City Council recently launching a new inspection campaign. The effort is aimed at ‘putting an end’ to clubs in the city, with city leadership stating that “It is a model that we do not want in our city.”

Cannabis clubs in Barcelona have long benefitted from a favorable tolerance of cannabis clubs, which operate in a legal ‘grey area’ of sorts. Commercial adult-use cannabis is still prohibited in Spain, however, it is unconstitutional for Spain’s government to prohibit private cannabis use.

Law enforcement in the Barcelona region of Spain estimates that the area is home to roughly 450 clubs, all of which are essentially unregulated. The clubs are very popular, and even if one is closed down another one pops up to take its place in short order. An effort to close down all of them is an untenable goal by every measure.

Cannabis prohibition is a failed public policy, with no hard evidence existing to back up the claim that it works. Prohibition does not lower consumption rates. Humans have made use of the cannabis plant for thousands of years, and that will never cease to be the case. Barcelona is no exception.

Cannabis is so engrained into the culture of the Barcelona region that it is home to the largest cannabis super-conference on the planet, a collaborative effort between the world’s largest cannabis gathering, Spannabis, and the world’s leading B2B series, the International Cannabis Business Conference.

Barcelona is one of the top international cannabis destinations on earth, with people flocking to the city from all corners of the globe every spring. It’s one of the only places on the planet where cannabis consumers of all backgrounds agree about the quality of the cannabis being amazing, with the same being true about the interesting places in which to consume it in a private setting.

Nowhere else on earth can the same cannabis scene be found that exists in Barcelona, which is why people go there. It is arguably the number one cannabis tourist destination on earth right now.

Barcelona doesn’t have a cannabis use problem. Rather, Barcelona has a cannabis regulation problem, and that problem increases in size and scope with every passing year. Barcelona’s unregulated cannabis market is enormous, and it is largely controlled by organized crime right now.

That, in turn, creates public health outcome concerns with people consuming products that are not tested for contaminants, in addition to public safety concerns.

The best thing that Barcelona policymakers can do is to work to transition cannabis clubs in Barcelona into a regulated system, yet, that is not something that Barcelona politicians can do unilaterally. At one point Barcelona had a regulatory program, however, the Spanish Supreme Court halted the local program.

Ultimately, regulations need to be passed at the national level in Spain. Lawmakers need to recognize the reality of the situation, that cannabis clubs in Spain are here to stay, and that it is better from a public health strategy standpoint to regulate the cannabis industry rather than leaving it to organized crime to continue to fill the void.

5 Things Attendees Get From International Cannabis Business Conference Events

The International Cannabis Business Conference is hosting multiple events in different European countries in 2024, including the world’s largest super-conference in Barcelona in March and our flagship B2B conference in Berlin in April. Below are five benefits for attendees.

World-Class Networking Opportunities

Networking plays a vital role in every industry, and that is particularly true for the emerging legal cannabis industry. At the international level, networking is paramount to making a meaningful impact and gaining a foothold in the space. Many people who strike deals in this era will reap the rewards for decades to come as the industry continues to expand. Those deals are not struck via email solicitations. Face-to-face time is a must, and there is no better place to do that than at International Cannabis Business Conference events where attendees get to network with leaders from around the world in an environment that is conducive to generating deal flow.

Fun and Entertainment

The International Cannabis Business Conference has long served as the most exciting and entertaining event series on earth. In addition to providing world-class education and networking, the International Cannabis Business Conference has earned a global reputation for hosting the best events where attendees can work hard and play hard. It’s the only cannabis event series to ever feature multiple Grammy-nominated musical acts. International Cannabis Business Conference events are the perfect place to hang out with current friends, as well as to make new ones from all around the world.

Being A Part Of History

The European continent is in the midst of a cannabis policy revolution. The collective policy modernization efforts in multiple countries will, in turn, create an amazing situation for consumers who will be able to experience freedoms that have not been available since the dawn of prohibition. Future generations will look back on this exact era and likely consider it to be the turning point for the cannabis movement in Europe when nations finally got on the right side of history. International Cannabis Business Conference events provide attendees a front-row seat to these historic times, putting them right in the middle of it all.

Brand Exposure

Gaining a meaningful footprint in the cannabis industry at the international level is one of the most difficult endeavors that a company can embark on for several reasons, not the least of which is geographical logistics. The International Cannabis Business Conference is the only global event series with a truly international following and conferences feature a carefully curated experience completely focused on the cannabis industry at the worldwide level. It’s the ideal place for brands debuting products that are geared towards an international market.

Education

Cannabis reform is happening all over the globe right now, and keeping up with all of it is not an easy task, nor is figuring out how each country’s efforts fit into the larger global cannabis industry puzzle. The International Cannabis Business Conference brings true experts from all over the world to provide the best and most up-to-date information to attendees. Receiving that important and timely information straight from people at the forefront of policy reform and the global industry is invaluable.

What Will Happen In 2024 Within The Global Cannabis Industry?

It is the start of a new year for the emerging international cannabis industry, and 2024 is likely to be a pivotal one, particularly for the European continent. According to domestic lawmakers in Germany, the nation’s adult-use cannabis measure will hopefully take effect this April.

Germany, in many ways, is a metaphorical plug in the European cannabis legalization dam. Once Germany passes its adult-use measure it will likely open the floodgates for other European nations passing similar policy modernization measures.

Cannabis commerce is going to look different in Europe than it does in the Western Hemisphere. In Uruguay and Canada, where cannabis was legalized for adult use in 2013 and 2018 respectively, consumers have a wide array of options for obtaining legal cannabis.

Germany’s legalization model, which is likely to be mimicked by other nations, will have fewer options for consumers to choose from to source their cannabis. However, there is still plenty of potential for people wanting to pursue efforts in the nation’s industry if they have enough ingenuity.

The country’s model, parts of which already exist in a limited fashion in parts of Europe, will rely on personal cultivation, cannabis clubs, and eventually, regional pilot programs as sourcing models. If Germany does implement that model on a large scale in 2024, it’s virtually guaranteed that other countries in Europe will do the same.

One particular country in Europe to keep an eye on in 2024 is Italy. Activists already proved in the past that they could gather enough signatures to put a referendum before voters, and while that effort was ultimately dashed by the nation’s top Court, advocates are back at it, and this time they have reportedly tightened up the language of the measure they are promoting.

Hopefully if the signature drive is successful it will pass the legal test this time around.

North America’s legal industry is sure to continue its expansion during this next calendar year, although adult-use legalization at the federal level is likely to remain elusive in the United States specifically. In the meantime, state industries will continue to operate in a silo fashion in the U.S.

Legalization efforts in countries such as Mexico, Costa Rica, and Colombia will continue in 2024 to round out the Western Hemisphere. However, the final passage of a legalization measure in those nations is not likely to occur this year, with 2024 serving as more of a momentum-building year for efforts in those countries.

Unfortunately, it appears that the honeymoon phase for cannabis reform in Thailand has long since ended, and attempts to roll back the nation’s progressive cannabis policies will continue throughout the year. Most, if not all, of the other nations in the region will likely not be very active in 2024 from a cannabis standpoint outside of enforcing harsh prohibition policies.

As has been the case for several years now, South Africa is the most likely nation on its continent to see possible reform and industry fireworks in 2024. With that being said, much like Mexico, things seem to keep stalling in South Africa, so that could easily prove to be the case in 2024 too. We will all have to wait and see.

For the first time in Australia’s history, a national legalization measure was introduced into the nation’s Parliament last year. While it doesn’t seem likely that the bill will receive enough attention in 2024 to be pushed to the finish line, it’s a safe bet that it will boost momentum and drive the conversation forward in Australia in 2024.

The best place for cannabis policy and industry observers to focus their attention in 2024 if they want to see the most activity is clearly the European continent.

This year could see a significant amount of movement in several countries in Europe, and while the industry revenue statistics may not be initially as large as they are across the Atlantic Ocean, 2024 may end up being one of the most historic years in Europe’s cannabis movement timeline.

Talman Group Global Investment Forum Coming To Berlin In April 2024

The emerging legal cannabis industry is becoming a global phenomenon, with more nations than ever before having modernized their cannabis policies to permit legal cannabis research and commerce.

That spread of policy reform has, in turn, created tremendous potential at the international level for cannabis entrepreneurs, investors, and industry service providers.

It has also created significant opportunities for cannabis research, as well as product and process development.

The legal industry no longer operates in regional silos, and a major challenge currently facing the emerging international cannabis industry is the difficulty of effectively networking with people from all over the world.

Networking is vital to succeeding in nearly every industry, and that is particularly true of the cannabis industry.

As the legal industry continues its march across the globe it will become increasingly important to be in the right place at the right time, as it could literally mean the difference between success and failure.

The Talman Global Investment Forum in Berlin on April 15th is the ideal time and place to meet and network with cannabis leaders from all over the planet.

Europe is currently the most exciting place for cannabis policy modernization efforts and emerging cannabis industry opportunities, with Germany expected to pass a legalization measure in April, making it the perfect backdrop for the Talman Global Investment Forum.

Taking place on the eve of the International Cannabis Business Conference’s flagship B2B event in Berlin, Europe’s largest event of its kind, the Talman Global Investment Forum will bring together true leaders from top sectors and companies in the emerging cannabis space.

The goal of the event is to help facilitate meaningful networking, provide timely education, and stimulate deal flow potential among attendees. Rising industry sectors will be a major focus of the event, with speakers discussing how those sectors fit into the larger industry ecosystem.

With so much cannabis industry and policy activity occurring right now all over the world, it is becoming increasingly difficult for entrepreneurs, investors, and industry service providers to stay on top of everything. The Talman Global Investment Forum streamlines that process.

The Talman Global Investment Forum is an exclusive network that focuses on research and development, consulting, advocacy, and finance. The Talman network provides access to vital market info, capital investors, and exciting cutting-edge growth companies in the legal global cannabis market.

Additionally, the Talman Group network provides unparalleled access to opportunities in emerging areas of science as well as research and development, which are some of the fastest-growing sectors in the cannabis space.

The Talman Global Investment Forum in Berlin, which will be held at the iconic Hotel Adlon Kempinski Berlin, is investor-focused and serves as the number one place for intimate industry education and networking.

Rather than flying all over the planet trying to fit meetings into shifting schedules and other travel plans, people who are serious about succeeding in the emerging international cannabis industry should attend the Talman Global Investment Forum in Berlin in April. Purchase your tickets today before the event sells out.

Medical Cannabis Legalization Stalls In Ukraine

Roughly a week ago lawmakers in Ukraine passed a measure that would legalize cannabis for medical use in the country under certain circumstances. Unfortunately, before the nation’s president could sign the measure procedural actions taken by the opposition party Batkivshchyna have delayed the process.

Cannabis opponents in the Verkhovna Rada made significant efforts leading up to the successful vote for medical cannabis to try to prevent a vote from happening via the classic political tactic of introducing needless amendments to the measure being considered.

Those tactics may have failed at the time, however, the recent actions by members of the Batkivshchyna party make the future of medical cannabis in Ukraine murkier, to say the least. Per Marijuana Moment:

The leader of the Batkivshchyna (Fatherland) party, Yulia Tymoshenko, who has consistently opposed the measure, said recently that her party intends to appeal to the Constitutional Court to cancel the legislative vote because “the amendments to the bill were considered in a half-empty chamber,” according to a report in the New Voice of Ukraine.

Tymoshenko, a former prime minister of the country, claimed that the proposal would legalize “drug trafficking and the drug mafia in the country,” though the local news outlet said she failed to provide any evidence for those claims.

The recently passed measure, if it is ever signed into law by President Volodymyr Zelensky, would legalize medical cannabis for suffering patients diagnosed with ‘severe illnesses’ and post-traumatic stress disorder.

Cannabis is currently classified as a List I substance in Ukraine, and if the new measure becomes law, it would reschedule cannabis to List II. That rescheduling would allow cannabis to be prescribed for medical purposes.

Ukraine’s Agrarian Policy Ministry would regulate the nation’s medical cannabis program along with Ukraine’s Police and State Agency on Medicines according to the bill. Medical cannabis imports would be permitted, which would help increase the speed at which the nation’s medical cannabis program could become operational.

Japanese Health Ministry Bans Six Synthetic Cannabinoids

Japan’s Health Ministry moved to pass a ban on certain synthetic cannabinoids this week, citing reported illnesses by consumers who stated they consumed gummy products infused with synthetic cannabinoids.

All of the cannabinoids in question, which will be banned starting January 6, 2024, have a similar structure as hexahydrocannabihexol (HHCH). Japan’s Health Ministry implemented a ban on HHCH and any products infused with it earlier this month.

Back in November, five individuals reportedly became ill after “consuming gummies distributed by a man at a festival in western Tokyo.” Those reported illnesses were cited as the reason for banning HHCH earlier this month.

Tetrahydrocannabinol (THC) was already banned in Japan, however, lawmakers recently passed a measure to close a perceived loophole in the law. THC consumption was not expressly prohibited in Japan until earlier this month. People in Japan caught having consumed cannabis now face up to seven years in prison.

Products containing synthetic cannabinoids are popular with consumers in jurisdictions that prohibit THC, serving as an alternative to non-synthetic cannabis products. Multiple outlets in Japan were reportedly selling synthetic cannabis products such as gummies and cookies before the passage of the ban.

Synthetic cannabis products are almost always unregulated, and thus, not always safe for human consumption. Growing demand for synthetic cannabis products is a byproduct of cannabis prohibition, as demonstrated by the fact that synthetic cannabis products are not nearly as popular, nor as widely available, in jurisdictions where adult-use cannabis commerce is permitted compared to where it is prohibited.

Regulated THC products are demonstrably safer than unregulated synthetic cannabinoid products, which is why governments around the world would be wise to modernize their cannabis policies to permit adult-use cannabis commerce to boost public health outcomes.

In addition to banning HHCH earlier this month, lawmakers in Japan lifted a ban on cannabis-derived medications to permit the importation of such medical cannabis products as Epidiolex. Epidiolex is often prescribed for patients diagnosed with intractable epilepsy.

The Top Global Cannabis Stories Of 2023

This year was a big one from a cannabis perspective in terms of science, industry, and politics. Below is a round-up of the top stories from 2023 (in no particular order):

Cannabis History Made In Slovenia

Dr. Metka Paragi, the current Secretary for Health of the Slovenian Prime Minister’s cabinet, presented at the International Cannabis Business Conference in Bled, Slovenia in September. It was the first time in history that an incumbent at that level had ever presented at a global cannabis event.

CanG Introduced In Germany

The biggest story of 2023 was the introduction of Germany’s long-awaited legalization measure. While the measure did not receive full approval by the Bundestag in 2023, the measure’s formal introduction and approval by Germany’s Federal Cabinet was historic, adding to the overall momentum for reform across the European continent.

Raphael Mechoulam Passes Away

The cannabis community lost a legend in 2023 when internationally renowned cannabis scientist, the ‘Godfather of Cannabis Science,’ Professor Raphael Mechoulam passed away in March. Mechoulam is credited with making some of the most significant scientific cannabis-based discoveries in human history.

Japan Votes To Lift Ban On Cannabis-Derived Medications

Both chambers of Japan’s parliament approved a measure in 2023 that lifted the nation’s ban on cannabis-derived medications. The measure is limited in scope, however, it creates a legal path for qualifying patients to obtain medical cannabis products.

Luxembourg Passes National Legalization Measure

In mid-2023 lawmakers in Luxembourg approved a national adult-use legalization measure. The new law permits adults to cultivate up to 4 plants in their homes, as well as legally possess up to three grams of cannabis.

Legalization Moves Forward In South Africa

South Africa’s National Assembly approved an adult-use legalization measure this year. The measure is geared towards codifying a previous court decision from 2018 that struck down cannabis prohibition for individuals, and to boost the nation’s legal industry.

Medical Cannabis Trial Extended In France

The 2,540 suffering patients participating in a medical cannabis trial in France received good news in 2023. The safe access trial that they are participating in will be extended for at least another year.

Historic Measure Introduced In Australia

For the first time in Australia’s history, an adult-use cannabis legalization measure was introduced into the nation’s parliament. Greens Senator David Shoebridge introduced the ‘Legalising Cannabis Bill 2023’ which would permit the adult recreational use of cannabis across the country.

Hemp Leaves No Longer A Novel Food In The EU

A European Commission working group removed hemp leaves as a Novel Food under EU law in 2023. The policy change permits the sale of hemp-infused tea and tea-like products in member states.

First Cannabis Clubs Licensed In Malta

Malta became the first European nation to pass a national legalization measure back in 2021. This year, the country issued its first round of licenses to noncommercial cannabis clubs.

Advocates Push For Higher THC Limits In Canadian Edibles

Roughly five years after Canada passed its adult-use legalization measure, the amount of THC that is allowed in edibles has remained very low. Advocates started a push in 2023 to raise the THC limit from 10mgs per unit to 100mgs per unit.

Cannabis Pilot Programs Launch In The Netherlands

Limited adult-use cannabis commerce trials finally launched in the Netherlands in December after several delays. Cannabis trials were first proposed in the Netherlands in 2017 as part of a governing coalition agreement.

Pilot Programs Expand In Switzerland

Switzerland launched multiple adult-use cannabis pilot programs in 2023. The pilot programs permit consumers to make legal purchases from licensed retail outlets to help the national government collect local data regarding cannabis consumer purchasing habits.

Ukrainian Medical Cannabis Legalization Awaits Presidential Signature

Lawmakers in Ukraine gave final approval this week to a measure that would legalize cannabis for medical purposes in certain instances. The medical cannabis legalization measure now awaits the signature of President Volodymyr Zelensky, who is expected to sign it into law.

Ukraine’s legislative body, the Verkhovna Rada, approved the bill on Thursday with 248 ‘yes’ votes. The favorable vote comes after years of Ukrainian advocates pushing for medical cannabis legalization. Per Kyiv Post:

In the second reading, the Verkhovna Rada voted in favor of legalizing medical cannabis in Ukraine, passing the new law with a total of 248 votes, as reported by People’s Deputy Yaroslav Zheleznyak on Telegram.

The Servant of the People pro-presidential faction cast 178 votes in support of the bill, draft law No. 7457. However, the European Solidarity faction, led by former President Petro Poroshenko, and the Batkivshchyna faction, led by former Prime Minister Yulia Tymoshenko, did not support the document.

Cannabis opponents in the Verkhovna Rada made significant efforts in recent weeks to try to prevent a vote from happening via the classic political tactic of introducing needless amendments to the measure being considered.

The recently passed measure, if signed into law by President Volodymyr Zelensky, would legalize medical cannabis for suffering patients diagnosed with ‘severe illnesses’ and post-traumatic stress disorder.

Cannabis is currently classified as a List I substance in Ukraine, and if this new measure becomes law, it will reschedule cannabis to List II. That rescheduling will allow cannabis to be prescribed for medical purposes.

Ukraine’s Agrarian Policy Ministry will regulate the nation’s medical cannabis program along with Ukraine’s Police and State Agency on Medicines. Medical cannabis imports will be permitted, which should help increase the rate at which the nation’s medical cannabis program is operational.

The measure is scheduled to be implemented six months after it receives President Volodymyr Zelensky’s signature.